NDC 72359-001-02 - RETHYMIC
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 72359-001
- Requested NDC
- 72359-001-02
- Package NDCs from labels
- 72359-001-02, 72359-001-01
- Manufacturer
- Sumitomo Pharma America, Inc. | Sumitomo Pharma Switzerland GmbH
- Effective date
- 2025-10-31
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| RETHYMIC - Sumitomo Pharma America, Inc. | Sumitomo Pharma Switzerland GmbH | Sumitomo Pharma America, Inc. | Sumitomo Pharma Switzerland GmbH | 2025-10-31 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 72359-001-01 | RETHYMIC | 11 in 1 BOX | IMPLANT | 11 | 8 | |
| 72359-001-02 | RETHYMIC | 4 in 1 CONTAINER | IMPLANT | 4 | 8 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 72359-001-01 | EA - Each | 72359-001 | 06a43849-5e1a-4e0d-ab24-332524778a07 | 1 | 2021-11-09 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| RETHYMIC | ALLOGENIC THYMOCYTE-DEPLETED THYMUS TISSUE-AGDC | Sumitomo Pharma America, Inc. | e0022c28-8cda-4f1e-bcf1-1f440d37ec4a | 2025-10-31 | Warnings, Adverse reactions | BLA125685 72359-001-02 72359-001-01 72359-001 72359000102 2626469 2626464 6b1c53ef-4ff9-46ff-96ad-b0cb5609ec17 e0022c28-8cda-4f1e-bcf1-1f440d37ec4a XD66YK3YY3 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.